Beta-interferon and glatiramer acetate were effective for the treatment of multiple sclerosis, with cost-effectiveness ranging from £7000 to £34,000 per quality-adjusted life-year.
http://ift.tt/2xpWfMn
Πέμπτη 21 Σεπτεμβρίου 2017
Clinical effectiveness and cost-effectiveness of beta-interferon and glatiramer acetate for treating multiple sclerosis: systematic review and economic evaluation.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
-
Publication date: September 2017 Source: European Journal of Surgical Oncology (EJSO), Volume 43, Issue 9 http://ift.tt/2gezJ2D
-
Publication date: January–February 2018 Source: Materials Today, Volume 21, Issue 1 Author(s): David Bradley http://ift.tt/2BP...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου